Boc-Orn(pyrazinylcarbonyl)-OH is a protected amino acid derivative. Its structure features an L-ornithine backbone where the alpha-amino group is protected by a tert-butoxycarbonyl (Boc) group, and the side-chain amino group is acylated with a pyrazine-2-carboxylic acid moiety. This design makes it a specialized building block for peptide synthesis. This compound is primarily used in the research and development of novel peptide-based pharmaceuticals and bioactive peptides. The pyrazine ring introduces a heterocyclic, nitrogen-rich pharmacophore that can be crucial for enhancing binding affinity, modulating solubility, or serving as a bioisostere in drug design. It is a key intermediate in the solid-phase or solution-phase synthesis of peptides containing modified ornithine residues. As a non-natural, side-chain modified amino acid, it falls under the category of peptide mimetics or modified peptide building blocks. Its applications are centered in medicinal chemistry and life sciences research for creating peptide libraries, probes, and potential therapeutic candidates targeting various biological pathways.